tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Immunocore Holdings: Strong Kimmtrak Performance and Strategic Expansion Justify Buy Rating
PremiumRatingsImmunocore Holdings: Strong Kimmtrak Performance and Strategic Expansion Justify Buy Rating
2M ago
Immunocore reports Q2 EPS (20c), consensus (21c)
Premium
The Fly
Immunocore reports Q2 EPS (20c), consensus (21c)
2M ago
Immunocore Holdings’ Promising PRAME-Targeting Therapies Drive Buy Rating
Premium
Ratings
Immunocore Holdings’ Promising PRAME-Targeting Therapies Drive Buy Rating
4M ago
Immunocore Holdings Reports Strong Q1 2025 Performance
PremiumCompany AnnouncementsImmunocore Holdings Reports Strong Q1 2025 Performance
5M ago
Immunocore price target lowered to $52 from $66 at Barclays
Premium
The Fly
Immunocore price target lowered to $52 from $66 at Barclays
5M ago
Immunocore Holdings: Strong Sales Growth and Financial Position Justify Buy Rating
Premium
Ratings
Immunocore Holdings: Strong Sales Growth and Financial Position Justify Buy Rating
5M ago
Immunocore Holdings’ Promising HIV Immunotherapy Advances Justify Buy Rating
PremiumRatingsImmunocore Holdings’ Promising HIV Immunotherapy Advances Justify Buy Rating
7M ago
Positive Outlook on Immunocore Holdings’ Innovative HIV Program Justifies Buy Rating
Premium
Ratings
Positive Outlook on Immunocore Holdings’ Innovative HIV Program Justifies Buy Rating
7M ago
Immunocore Holdings Reveals Promising HIV Trial Results
Premium
Company Announcements
Immunocore Holdings Reveals Promising HIV Trial Results
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100